The National Institutes of Health (NIH) is inviting applications for Exploratory/Developmental Research Grant. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications for cancer epidemiologic research. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as improving data collection methods, developing and validating methods of exposures and biological effects, such as epigenetics and metabolomics, and their application in population-based research, functional assessment of genetic variants, and assessing recruitment methods for understudied populations.
Eligibility
- Higher Education Institutions both public and private
- Nonprofits Other Than Institutions of Higher Education
- For-Profit Organizations(small business)
- Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply
- Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
- Foreign components, as defined in the NIH Grants Policy Statement, are allowed to apply
- Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.
- Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year
Funder: National Institute of Health (NIH)
URL: https://grants.nih.gov/grants/guide/pa-files/PAR-19-277.html
Deadline: October 16th 2021, February 16th 2022
